Close
Help
Need Help?



Genetics & Epigenetics Email Alerts

Posted Tue, May, 15,2012

A key component of Libertas' high quality service to Genetics & Epigenetics authors and readers is the free email alerts service, which keeps recipients updated on Genetics & Epigenetics newly published articles and journal news.

Email alerts recipients receive short, plain text notifications whenever a new article is published.  Notifications are also provided for forthcoming papers and journal news items.  No more than one email is sent per day and all emails are plain text, making them easy to read and quick to download on mobile devices.

You may unsubscribe at anytime through My LA or with the unsubscribe function provided in each email you will receive.  You will not receive emails on any other subject and your details will be kept confidential.

Visit the email sign up page now

share on

Posted in: Libertas Services

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
It is my pleasure to confirm that we had a very pleasant experience by publishing our article in Clinical Medicine Insights: Therapeutics.  The review process was highly efficient and the reviewers' comments useful and constructive.  I am sure that this is the kind of publication needed by the scientific community.  I am looking forward future collaborations.
Dr Federico Navarro Sarabia (University Hospital Virgen Macarena, Sevilla, Spain)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results